UniProt Q0TR53
O-GlcNAcase NagJ (Q0TR53)
O-GlcNAcase NagJ (UniProt Q0TR53), EC 3.2.1.169, 3.2.1.52: 33 experimental structures and 1 predicted model on GenesisL1, 8 ligands bound, 44 pockets. Binding sites, druggability and experiment against prediction (TM-score) in…
- UniProt
- Q0TR53
- Protein
- O-GlcNAcase NagJ
- EC
- 3.2.1.169, 3.2.1.52
- Experimental structures
- 33
- Predicted models
- 1
- Ligands
- 8
- Pockets
- 44 · 4 records with a druggable one
Structures
34 records of Q0TR53 in the MolNFT archive: 33 experimental, 1 predicted.
| Entry | Title | Method | Chains | Ligands | Pockets |
|---|---|---|---|---|---|
| 2J62 | Structure of a bacterial O-glcnacase in complex with glcnacstatin | x-ray diffraction | A, B | — | — |
| 2J62 | Structure of a bacterial O-glcnacase in complex with glcnacstatin | x-ray diffraction | A, B | — | — |
| 2JH2 | X-ray crystal structure of a cohesin-like module from Clostridium perfringens | x-ray diffraction | A, B, C | — | 3 (best 0.52) |
| 2JH2 | X-ray crystal structure of a cohesin-like module from clostridium perfringens | x-ray diffraction | A, B, C | — | — |
| 2O4E | The solution structure of a protein-protein interaction module from a family 84 glycoside hydrolase… | solution nmr | A | — | — |
| 2O4E | The solution structure of a protein-protein interaction module from a family 84 glycoside hydrolase… | solution nmr | A | — | — |
| 2OZN | The Cohesin-Dockerin Complex of NagJ and NagH from Clostridium perfringens | x-ray diffraction | A | — | — |
| 2OZN | The cohesin-dockerin complex of nagj and nagh from clostridium perfringens | x-ray diffraction | A | — | — |
| 2V5C | Family 84 glycoside hydrolase from Clostridium perfringens, 2.1 Angstrom structure | x-ray diffraction | A, B | — | — |
| 2V5C | Family 84 glycoside hydrolase from clostridium perfringens, 2.1 ångström structure | x-ray diffraction | A, B | — | — |
| 2V5D | Structure of a Family 84 Glycoside Hydrolase and a Family 32 Carbohydrate-Binding Module in Tandem… | x-ray diffraction | A | — | — |
| 2V5D | Structure of a family 84 glycoside hydrolase and a family 32 carbohydrate-binding module in tandem… | x-ray diffraction | A | — | — |
| 2VUR | Chemical dissection of the link between Streptozotocin, O-GlcNAc and pancreatic cell death | x-ray diffraction | A, B | — | — |
| 2VUR | Chemical dissection of the link between streptozotocin, O-glcnac and pancreatic cell death | x-ray diffraction | A, B | — | — |
| 2WB5 | GlcNAcstatins are nanomolar inhibitors of human O-GlcNAcase inducing cellular hyper-O-GlcNAcylation | x-ray diffraction | A, B | — | — |
| 2WB5 | Glcnacstatins are nanomolar inhibitors of human O-glcnacase inducing cellular hyper-O-glcnacylation | x-ray diffraction | A, B | — | — |
| 2X0Y | Screening-based discovery of drug-like O-GlcNAcase inhibitor scaffolds | x-ray diffraction | A, B | — | — |
| 2X0Y | Screening-based discovery of drug-like O-glcnacase inhibitor scaffolds | x-ray diffraction | A, B | — | — |
| 2XPK | Cell-penetrant, nanomolar O-GlcNAcase inhibitors selective against lysosomal hexosaminidases | x-ray diffraction | A, B | — | — |
| 2XPK | Cell-penetrant, nanomolar O-glcnacase inhibitors selective against lysosomal hexosaminidases | x-ray diffraction | A, B | — | — |
| 2YDQ | CpOGA D298N in complex with hOGA-derived O-GlcNAc peptide | x-ray diffraction | A | — | — |
| 2YDQ | Cpoga D298N in complex with hoga-derived O-glcnac peptide | x-ray diffraction | A | — | — |
| 2YDR | CpOGA D298N in complex with p53-derived O-GlcNAc peptide | x-ray diffraction | A | — | — |
| 2YDR | Cpoga D298N in complex with P53-derived O-glcnac peptide | x-ray diffraction | A | — | — |
| 2YDS | CpOGA D298N in complex with TAB1-derived O-GlcNAc peptide | x-ray diffraction | A | — | — |
| 2YDS | Cpoga D298N in complex with TAB1-derived O-glcnac peptide | x-ray diffraction | A | — | — |
| 4ZXL | CpOGA D298N in complex with Drosophila HCF -derived Thr-O-GlcNAc peptide | x-ray diffraction | A | NAG, CD | 7 (best 0.45) |
| 4ZXL | Cpoga D298N in complex with drosophila hcf -derived thr-O-glcnac peptide | x-ray diffraction | A | — | — |
| 5OXD | Complex of a C. perfringens O-glcnacase with a fragment hit | x-ray diffraction | A | CD, B2W | — |
| 6RHE | CpOGA D298N in complex with hOGA-derived S-GlcNAc peptide | x-ray diffraction | A | CD, NAG | 6 (best 0.70) |
| 6RHE | Cpoga D298N in complex with hoga-derived S-glcnac peptide | x-ray diffraction | A | NH2, CD, NAG | — |
| 7KHV | CpOGA IN COMPLEX WITH LIGAND 54 | x-ray diffraction | A, B, C, D, E, F | X1A, CA, SO4, CL | 20 (best 0.70) |
| 7KHV | Cpoga in complex with ligand 54 | x-ray diffraction | A, B, C, D, E, F | X1A, CA, SO4, CL | — |
| Q0TR53 | AlphaFold monomer V2.0 prediction for O-glcnacase nagj (Q0TR53) | predicted | A | — | 8 (best 0.56) |
Ligands
- CD · Cadmium ion · in 4 records
- NAG · 2-acetamido-2-deoxy-beta-D-glucopyranose · in 3 records
- CA · Calcium ion · in 2 records
- CL · Chloride ion · in 2 records
- SO4 · Sulfate ion · in 2 records
- X1A · N-(5-{[6-(5-methyl[1,2,4]triazolo[1,5-a]pyrimidin-7-yl)-2,6-diazaspiro[3.4]octan-2-yl]methyl}-1,3-thiazol-2-yl)acetamide · in 2 records
- B2W · 5-(trifluoromethyl)-2,3-dihydro-1~{H}-1,4-diazepine · in 1 record
- NH2 · Amino group · in 1 record
Experiment against prediction
- 7KHV chain A against the predicted model Q0TR53: TM-score 1.00, RMSD 0.50 Å
- 7KHV chain A against the predicted model Q0TR53: TM-score 1.00, RMSD 0.50 Å
- 7KHV chain D against the predicted model Q0TR53: TM-score 1.00, RMSD 0.55 Å
- 7KHV chain E against the predicted model Q0TR53: TM-score 1.00, RMSD 0.55 Å
- 7KHV chain F against the predicted model Q0TR53: TM-score 1.00, RMSD 0.54 Å
- 7KHV chain F against the predicted model Q0TR53: TM-score 1.00, RMSD 0.54 Å
- 2YDQ chain A against the predicted model Q0TR53: TM-score 0.99, RMSD 0.68 Å
- 2YDQ chain A against the predicted model Q0TR53: TM-score 0.99, RMSD 0.68 Å
- 2YDS chain A against the predicted model Q0TR53: TM-score 0.99, RMSD 0.70 Å
- 2YDS chain A against the predicted model Q0TR53: TM-score 0.99, RMSD 0.70 Å
Elsewhere
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.